FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Modern Mobility Aids, Inc. Stock AnalysisComprehensive stock analysis for Modern Mobility Aids, Inc. (MDRM) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMDRM
MDRM
Modern Mobility Aids, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MDRM
Home🔹Stocks🔹Modern Mobility Aids, Inc.

Modern Mobility Aids, Inc.

🇺🇸MDRM•OTC

Modern Mobility Aids, Inc.

🇺🇸MDRM•OTC
Market cap
$510.19K
Sentiment

Your view on MDRM

Mkt Cap
$510.19K
Sentiment
Your view
MDRM
Modern Mobility Aids, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MDRM
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Modern Mobility Aids, Inc.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Tito DiMarco
Headquarters
79 Bramsteele Road, Brampton, ON, CA
Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Tito DiMarco
Headquarters
79 Bramsteele Road, Brampton, ON, CA
Description

Modern Mobility Aids Inc. is dedicated to reshaping the conventional in-person clinic and doctor's office experience by implementing a unique telehealth platform that replicates face-to-face consultations using cutting-edge software, medical devices and AI.

This groundbreaking method facilitates real-time connections between patients and doctors, empowering physicians to conduct thorough examinations as if patients were physically present in their office. Make a social impact investment where it matters most. People's health. For additional information please visit www.modernmobilityaids.com.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Modern Mobility Aids, Inc., and the rating behind it. MDRM last traded at $0.0040; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Modern Mobility Aids, Inc.. Starting points for Modern Mobility Aids, Inc.: beta -0.44 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Modern Mobility Aids, Inc.. Modern Mobility Aids, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Modern Mobility Aids, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Modern Mobility Aids, Inc.. Modern Mobility Aids, Inc. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Modern Mobility Aids, Inc. valued side by side against its closest peers. Modern Mobility Aids, Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Modern Mobility Aids, Inc., and how their positions are changing. At a $510,192 market value, institutional positions materially move Modern Mobility Aids, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Modern Mobility Aids, Inc. executives and directors. Shares of Modern Mobility Aids, Inc. have traded between $0.0010 and $0.01 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Modern Mobility Aids, Inc.. Modern Mobility Aids, Inc. is a $510,192 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Modern Mobility Aids, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Modern Mobility Aids, Inc.. Coverage tracks Modern Mobility Aids, Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • BNGI — Bangi Inc.
  • BPTSY — Biophytis S.A.
  • EVAHF — EGF Theramed Health Corp.
  • GEATF — Radiko Holdings Corp.
  • IDYLF — Imaging Dynamics Company Ltd.
  • MDNWF — Mednow Inc.
  • NDATF — nDatalyze Corp.
  • STEK — Stemtech Corporation

More Medical - Pharmaceuticals companies

  • PLWY — Peoplesway.com Inc.
  • PNDHF — Pond Technologies Holdings Inc.
  • PNPL — Pineapple, Inc.
  • POM — POMDOCTOR Ltd
  • PRPH — ProPhase Labs, Inc.
  • PXYN — Praxsyn Corporation
  • QMDT — Quick-Med Technologies, Inc.
  • RADLY — Raia Drogasil S.A.
  • RBII — Rising BioSciences, Inc.
  • RCDTF — Recordati Industria Chimica e Farmaceutica S.p.A.
  • RGEDF — Gedeon Richter PLC
  • RLLVF — Relevium Technologies Inc.

News

Latest Market News